Prostatis Group LLC Regeneron Pharmaceuticals, Inc. Transaction History

Prostatis Group LLC

  • $215 Billion
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Mar 23, 2023
SELL
$548.35 - $738.84 $8.43 Million - $11.4 Million
-15,370 Closed
0 $0
Q1 2022

Mar 23, 2023
BUY
$595.12 - $698.43 $876,016 - $1.03 Million
1,472 Added 10.59%
15,370 $18.9 Million
Q4 2021

Mar 23, 2023
BUY
$543.48 - $670.97 $317,392 - $391,846
584 Added 4.39%
13,898 $17.1 Million
Q3 2021

Mar 23, 2023
BUY
$574.03 - $680.96 $7.64 Million - $9.07 Million
13,314 New
13,314 $13.3 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email